Skip to main content

Table 1 Laboratory data at admission

From: Kocuria kristinae septic arthritis associated with infectious endocarditis in a hemodialysis patient with diabetes mellitus: a case report and literature review

CBC (normal range) Blood chemistry Tumor markers Blood culture
 RBC (400–552) 239 × 104/mm3  FBS (70–110) 179 mg/dL  CEA (<3.4) 0.8 ng/mL Kocuria kristinae (+)
  Hb (13.2–17.2) 6.9 g/dL  Alp (104–338) 501 U/L  CA19-9 (<37) 2.8 U/mL  Antimicrobial susceptibilities (MIC) μg/mL
  Ht (40.4–51.1) 21.9 %  γ-GTP (5–70) 41 U/L Infection     Penicillin 0.12
 Plt (14.8–33.9) 46.8 × 104/mm3  t-Bil (0.2–1.2) 0.3 mg/dL  HBs Ag (−)   Oxacillin ≤2.0
 WBC (3.6–9.6) 5.6 × 103/mm3  d-Bil (0–0.4) 0.0 mg/dL  HCV Ab (−)   Ampicillin ≤0.25
  neu 73.0 %  ChE (168–470) 123 U/L  HTLV-I Ab (−)   Cefazolin ≤8.0
  lym 8.0 %  ALT (8–42) 24 U/L  EBV     Cefotaxime ≤8.0
  mon 13.0 %  AST (13–33) 37 U/L   VCA-IgG ×640   cefepime ≤8.0
  eos 6.0 %  LDH (119–229) 125 U/L   VCA-IgM ×<10   Cefotiam ≤8.0
  bas 0.0 %  CPK (62–287) 10 U/L   EBNA ×20   Cefpirome ≤8.0
  aty-ly 0.0 %  Crn (0.6–1.1) 10.3 mg/dL  Mumps (−)   Cefozopran ≤8.0
Electrolytes    BUN (8–20) 52 mg/dL  Herpes zoster (−)   Cefmetazole ≤16.0
 Na (136–145) 137 mmol/L  UA (3.4–7.8) 8.5 mg/dL  Parvovirus B19 (−)   Cefdinir ≤1.0
 K (3.4–4.5) 4.4 mmol/L  Amy (37–125) 71 U/L  Syphilis (−)   Cefditoren ≤1.0
 Cl (100–108) 99 mmol/L  TG (30–150) 106 mg/dL  QFT (−)   Flomoxef ≤8.0
 Ca (8.7–11.0) 10.2 mg/dL  H-Chol (>40) 17 mg/dL  Candida Ab (−)   Imipenem/cilastatin ≤4.0
 P (2.5–4.5) 4.7 mg/dL  L-Chol (<140) 61 mg/dL  β-d-glucan (−)   Meropenem ≤4.0
 Mg (1.8–2.4) 2.5 mg/dL Serological examinations    Chlamydia trachomatis     Amoxicillin ≤4.0
Proteinogram    CRP (<0.3) 35.5 mg/dL   IgG (−)   Gentamicin ≤4.0
 TP (6.7–8.1) 7.1 g/dL  SAA (<8.0) 1843.9 mg/mL   IgA (−)   Amikacin ≤16.0
 Alb (3.9–4.9) 2.6 g/dL  MMP-3 (36.9–121.0) 586.4 ng/mL  Chlamydia pneumoniae     Arbekacin ≤4.0
 Glb 4.5 g/dL  CH50 (30–45) 47.0 U/mL   IgG (−)   Erythromycin ≤0.5
  α1 11.2 %  C3 (65–135) 131.5 mg/dL   IgA (−)   Clarithromycin ≤2.0
  α2 16.6 %  C4 (13–35) 31.7 mg/dL Synovial fluid     Clindamycin ≤0.5
  β 10.7 %  ANA (−)  Glossly purulent material     Minocycline ≤4.0
  γ 34.3 %  ds-DNA Ab (−)  WBC 13,200 × 103/mm3   Linezolid ≤2.0
 IgG (870–1700) 2519 mg/dL  SSA Ab (−)   neu 95.0 %   Vancomycin ≤2.0
 IgA (110–410) 497 mg/dL  SSB Ab (−)   pla 5.0 %   Teicoplanin ≤8.0
 IgM (35–220) 87 mg/dL  RF (−)  Crystals (−)   Fosfomycin ≤4.0
 M-protein (−)  ACPA (−)  Culture (−)   Levofloxacin ≤1.0
 HbA1c (4.6–6.2) 7.9 %  MPO-ANCA (−)      Sulfamethoxazole/trimethoprim ≤2.0
ESR (<20) >140 mm/h  PR3-ANCA (−)      Rifampicin ≤1.0
  1. Abbreviations: CBC complete blood cell count, RBC red blood cell count, Hb hemoglobin, Ht hematocrit, Plt platelet, ESR erythrocyte sedimentation rate, WBC white blood cell count, neu neutrophils, lym lymphocytes, mon monocytes, eoseosinophils, bas basophils, aty-ly atypical lymphocytes, Na sodium, K potassium, Cl chlorine, Ca calcium, P phosphorus, Mg magnesium, TP total protein, Alb albumin, Glb globulin, IgG immunoglobulin G, IgA immunoglobulin A, IgM immunoglobulin M, FBS fasting blood sugar, Alp alkaline phosphatase, γ-GTP γ-glutamyltransferase, t-Bil total bilirubin, d-Bil direct bilirubin, ChE cholinesterase, ALT alanine transaminase, AST aspartate aminotransferase, LDH lactate dehydrogenase, CPK creatine phosphokinase, Crn creatinine, BUN blood urea nitrogen, UA uric acid, Amy amylase, TG triglyceride, H-Chol high-density lipoprotein cholesterol, L-Chol low-density lipoprotein cholesterol, CRP C-reactive protein, SAA serum amyloid A, MMP-3 matrix metalloproteinase-3, CH50 complement activity, C3 complement 3, C4 complement 4, ANA antinuclear antibody, SSA Ab anti-SS-A/Ro antibody,SSB Ab anti-SS-B/La antibody, RF rheumatoid factor, ACPA anti-cyclic citrullinated peptide antibody, MPO-ANCA myeloperoxidase-anti-neutrophil cytoplasmic antibody, PR3-ANCA serine proteinase3-anti-neutrophil cytoplasmic antibody, HBs Ab hepatitis B surface antigen, HCV Ab hepatitis C virus antibody, HTLV-I Ab human T-lymphotropic virus type 1 antibody,pla plasma cell, EBV Epstein-Barr virus, VCA viral capsid antigen, EBNA Epstein-Barr nuclear antigen, QFT QuantiFERON-TB, pla plasma cell